Dec 11, 20201 min

Biopharma Stock Updates - 12/11/20 | GILD, BTNX, IPHA...

Data Updates:

$GILD (+0.5) - New Data From Phase 3 ASCENT Trial

http://investors.gilead.com/news-releases/news-release-details/gilead-advances-oncology-portfolio-new-data-phase-3-ascent-trial

$PFE & $BNTX (-1.17) – ADCOM voted in favor of emergency use Covid vaccine

https://biontechse.gcs-web.com/news-releases/news-release-details/pfizer-and-biontech-receive-fda-advisory-committee-vote

$IPHA (-18.66) – Returns US and EU Lumoxiti commercialization rights to AstraZeneca

https://investors.innate-pharma.com/news-releases/news-release-details/innate-pharma-return-us-and-eu-lumoxiti-commercialization-rights

$XERS (+11.74) – Positive CHMP Opinion for OGLUO

https://investors.xerispharma.com/news-releases/news-release-details/xeris-pharmaceuticals-receives-positive-chmp-opinion-ogluotm-its

$GALT (-0.76) – Present at 4th Annual Digital NASH summit on December 17, 2020

https://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-inc-present-4th-annual-digital-nash-summit

$ODT (-1.25) – Positive Results of CONTESSA

https://ir.odonate.com/press-releases/2020-12-11-positive-results-of-contessa--a-phase-3-study-of-tesetaxel-in-patients-with-metastatic-breast-cancer--presented-at-the-2020-san-antonio-breast-cancer-symposium--sabcs--34efcaba-1739-4df6-9d83-e80207e193ea

Financial Updates:

$FMTX (+1.49) – Priced offering at $42.25/share

https://ir.formatherapeutics.com/news-releases/news-release-details/forma-therapeutics-announces-pricing-public-offering

$PTGX (-0.04) – Pricing of $100 Million Public Offering of Common Stock

https://investors.protagonist-inc.com/news-releases/news-release-details/protagonist-therapeutics-inc-announces-pricing-100-million

$SLDB (+51.62) – $90 Million Private Placement

https://investors.solidbio.com/news-releases/news-release-details/solid-biosciences-announces-90-million-private-placement

$KURA (+2.34) – Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

https://ir.kuraoncology.com/news-releases/news-release-details/kura-oncology-announces-closing-public-offering-and-full-2

$ALBO (-3.04) – Inducement Grant under Nasdaq Listing Rules 5635(c)(4)

https://ir.albireopharma.com/news-releases/news-release-details/albireo-reports-inducement-grant-under-nasdaq-listing-rule-0

$SNDX (-3.84) – Closing of Public Offering and Exercise in Full

http://ir.syndax.com/news-releases/news-release-details/syndax-announces-closing-public-offering-and-exercise-full

$PBYI (+1.17) – Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

https://investor.pumabiotechnology.com/news-releases/news-details/2020/Puma-Biotechnology-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4-d25b9528e/default.aspx

    0